NEW YORK ( TheStreet) -- CHANGE IN RATINGS
Brady (BRC) upgraded to buy at TheStreet Ratings.
Brown-Forman (BF.B) upgraded at DA Davidson from Neutral to Buy, DA Davidson said. $75 price target. Estimates also boosted, as the company can gain market share in a solid industry.Chevron (CVX - Get Report) upgraded at Dahlman from Hold to Buy, Dahlman Rose said. $120 price target. Gorgon LNC project costs will likely be in-line with expectations. Freeport-McMoran (FCX - Get Report) downgraded at Deutsche from Buy to Hold, Deutsche Bank said. $40 price target. Acquisitions are a big change in strategy and very dilutive. Freeport-McMoran downgraded at Goldman from Buy to Neutral, Goldman Sachs said. $38 price target. Proposed acquisitions put the stock in the penalty box. Freeport-McMoran downgraded at BMO to Market Perform, BMO Capital said. $30 price target. Acquisitions add a lot of debt and change the company's strategy. Freeport-McMoRan downgraded at Citigroup to Neutral from Buy, Citigroup said. $35 price target. Recent acquisitions appear dilutive. Fusion-io (FIO) rated new Buy at BofA/Merrill. $30 price target. Company is a clear market leader in an industry with low penetration. W.W. Grainger (GWW) downgraded at UBS to Neutral from Buy, UBS said. $202 price target. Market share outlook deteriorates. Lions Gate (LGF) rated new Neutral at Goldman Sachs. $18 price target. Valuation call, as the stock is up 92% year-to-date. Mellanox (MLNX) rated new Neutral at UBS. $70 price target. Strong fundamentals, but valuation full. Ocwen Financial (OCN) upgraded at KBW from Market Perform to Outperform, Keefe, Bruyette & Woods said. $40 price target. Stock is attractive, following the recent selloff. Starbucks (SBUX - Get Report) upgraded at Baird to Outperform from Neutral, Robert Baird said. $62 price target. Company can deliver solid earnings momentum over the next 12-24 months. Scripps Networks (SNI) downgraded at Goldman from Buy to Neutral, Goldman Sachs said. $65 price target. Estimates also reduced, given lower Food Network ratings. Solar Capital (SLRC) upgraded to buy at TheStreet Ratings.
Stock Comments / EPS ChangesCanadian Pacific (CP) numbers raised at Citigroup Dec 06, 2012 | 8:17 AM EST Shares of CP now seen reaching $111, Citigroup said. Estimates also increased as turnaround transition to execution. El Paso Electric (EE) numbers lowered at Jefferies. Shares of EE now seen reaching $32, Jefferies said. Estimates also lowered on loss of AFUDC contribution. Hold rating. Lowe's (LOW) numbers raised at Jefferies. Shares of LOW now seen reaching $32, Jefferies said. Estimates also raised on positive analyst meeting. Hold rating. Mednax (MD) estimates, target raised at Piper. Shares of MD now seen reaching $91, according to Piper Jaffray. Estimates also increased, given Medicare rate parity. Overweight rating. MarketAxess (MKTX) numbers increased at BMO. MKTX estimates were raised through 2014, BMO Capital said. Company is leveraged to higher cash credit activity and is also taking market share. Market Perform rating and new $34 price target. AT&T (T - Get Report) estimates, target cut at Guggenheim. Shares of T now seen reaching $33.50, according to Guggenheim. Estimates also reduced, given higher expected smartphone subsidies. Neutral rating. Vera Bradley (VRA) numbers raised at Jefferies. Shares of VRA now seen reaching $22, Jefferies said. Estimates also raised on all around solid quarter. Hold rating. Verint (VRNT) estimates, target lowered at JP Morgan. Shares of VRNT now seen reaching $35.50, according to JP Morgan. Estimates also cut, given a weaker business mix and slower growth in Europe. Overweight rating. Verint Systems numbers lowered at Oppenheimer. Shares of VRNT now seen reaching $41, Oppenheimer said. Estimates also lowered on near- term headwinds in Europe. Outperform rating. >To submit a news tip, email: firstname.lastname@example.org.
Twitter and become a fan on Facebook.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts